NIKE, Inc. (NKE) Stock Analysis
Is NKE a good investment?
NIKE, Inc. (NKE) has a Plutrex AI rating of 22.0/100 as of October 10, 2026, indicating a Strong Sell consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Cash position of $8.368B and FCF of $2.105B provide genuine balance sheet floor — dividend ($0.01/share quarterly, ~4.8% yield) and share buybacks remain sustainable without imminent liquidity crisis, preventing catastrophic collapse to zero. Main concern: Analyst consensus target collapsed from $47.19 to $35.98 (-23.8% in 14 days) — institutional recovery thesis has been abandoned; with only 3.7% upside to target from $34.71, there is no longer a valuation backstop; simultaneously, China revenue -28% in Q1 FY2027 confirms the largest growth region is in freefall, making the revenue recovery timeline completely uncertain.
Investment Summary
Nike (NKE) at $34.71 is a deteriorating consumer brand in structural decline, warranting a Strong Sell rating with high conviction. The investment case has worsened materially since our prior report 14 days ago. Critically: analyst consensus target collapsed from $47.19 to $35.98 (-23.8%), implying only 3.7% upside vs. prior 32% — the institutional backstop has effectively evaporated. Revenue contraction deepened from -1.1% to -4.3% (a -290.9% move). China revenue crashed 28% in Q1 FY2027, a catastrophic top-line indicator for a brand that generates ~15-20% of revenues from the region. The P/E of 16.64x on 5-year EPS CAGR of -3.9% is mathematically unjustifiable — you are paying a market multiple for a shrinking earnings stream. Operating margin of 7.92% vs. industry average 10.72% (-26.1% discount) and net margin of 6.74% vs. peer average 8.78% confirm the cost structure is broken. The stock is down 77-81% from all-time highs and the dividend yield of 4.8% is a distress signal, not an income opportunity — it reflects price collapse, not dividend growth. With the analyst target now barely above current price ($35.98 vs. $34.71), the institutional 'recovery' thesis has been abandoned.
Key Strengths
- Cash position of $8.368B and FCF of $2.105B provide genuine balance sheet floor — dividend ($0.01/share quarterly, ~4.8% yield) and share buybacks remain sustainable without imminent liquidity crisis, preventing catastrophic collapse to zero
- Near-term EPS recovery of 18.24% next year slightly exceeds industry average of 17.38% — restructuring actions (extended to fiscal 2031) are expected to deliver marginal short-term cost benefits, providing a temporary earnings floor
- Brand equity and global distribution scale (150+ countries) represent a qualitative moat that financial metrics cannot fully capture — the brand has survived multiple prior downturns and retains consumer recognition globally
Key Concerns
- Analyst consensus target collapsed from $47.19 to $35.98 (-23.8% in 14 days) — institutional recovery thesis has been abandoned; with only 3.7% upside to target from $34.71, there is no longer a valuation backstop; simultaneously, China revenue -28% in Q1 FY2027 confirms the largest growth region is in freefall, making the revenue recovery timeline completely uncertain
- 5-year EPS CAGR of -3.9% vs. industry average +6.19% (a 1,008bps gap) renders the P/E of 16.64x — already at a 5.9% premium to peers — fundamentally unjustifiable; with PEG undefined due to negative growth, Nike trades as the most overvalued stock in the peer group on every growth-adjusted basis; at -81% from all-time highs and revenue contracting -4.3%, there is no credible near-term catalyst to justify current pricing
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Revenue growth of -4.3% YoY (vs. industry +1.51%) signals active market share erosion, not cyclical weakness. Operating margin of 7.92% vs. industry average 10.72% — a 280bps gap — reveals bloated SG&A and restructuring costs consuming over 35 percentage points between gross (43.3%) and operating margin (7.9%). Net margin of 6.74% vs. peer average 8.78% (-23.2% discount). ROE of 21.56% vs. industry 23.37% — buyback-aided but below peer average. P/E of 16.64x vs. industry 15.72x — Nike trades at a 5.9% PREMIUM to peers despite catastrophically inferior fundamentals. PEG is mathematically undefined (negative 5-year EPS CAGR of -3.9%) vs. industry PEG of 0.99x — Nike is the only major peer that cannot be valued on a growth-adjusted basis. FCF of $2.105B and cash of $8.368B are genuine strengths, but cash has declined from $9.027B in the prior period (-$659M), and FCF compression will continue with revenue contraction. Debt-to-equity of 0.56 is marginally above peer average of 0.54 — not a crisis but no advantage. The 5-year EPS CAGR of -3.9% vs. industry +6.19% is a 1,008bps structural gap — the dominant fundamental concern and a genuine disqualifier for long-term investment.
News Sentiment
Nike's stock is experiencing one of the most dramatic falls from grace in American corporate history, and the latest headlines paint a grim picture for the iconic swoosh. The company's earnings have been described as 'a disaster' — and that headline from financial media is not hyperbole. China, once Nike's most promising growth engine, saw revenues crater 28% in Q1 FY2027, as Chinese consumers increasingly prefer homegrown brands like Li-Ning and Anta over Western labels. Meanwhile, Nike's stock has declined 77-81% from its all-time high, destroying billions in shareholder value over five years of strategic missteps, brand missteps, and a consumer spending environment that has turned sharply against premium athletic wear. Headlines asking 'Is Buying Nike a Brilliant Move or a Disaster?' reflect genuine investor confusion — but the data tilts heavily toward disaster. The 4.8% dividend yield that headlines are calling 'record' is not a sign of generosity; it's a mathematical result of the share price collapse. Multiple articles explore whether Nike represents a 'generational buying opportunity' at -81% from highs — the honest answer is: not yet. Revenue is still contracting at -4.3%, analysts have slashed their price targets from $47 to $36, and there is no credible timeline for a China recovery. The restructuring program extended to fiscal 2031 suggests management itself sees this as a multi-year ordeal, not a quick fix. For everyday investors, the message is clear: the swoosh may survive, but catching this falling knife remains extremely dangerous.
Risk Assessment
PRIMARY RISK: The analyst target collapse from $47.19 to $35.98 in 14 days signals institutional capitulation — if analysts continue cutting targets (now barely above current price), downside momentum accelerates with no valuation support. CHINA RISK: -28% revenue decline in Q1 FY2027 from the key growth market is structural, not cyclical — domestic Chinese brands (Li-Ning, Anta) are permanently displacing Nike at multiple price points. DIVIDEND RISK: A 4.8% yield driven by price collapse (not dividend growth) means the dividend becomes unsustainable if FCF continues compressing — a cut would trigger another leg down. UPSIDE RISK (bear case mitigation): If Elliott Management or another activist takes a position and forces asset monetization or a major strategic pivot, the brand equity could be unlocked. Bull case requires China stabilization + US market share recovery + margin restoration — a 3-4 year journey at minimum. ENTRY MATH: Graham formula: EPS ~$2.10 × (8.5 + 2×(-3.9%)) = $14.28 (negative growth case). PEG=1.0 fair value: industry PEG of 0.99x is useless for Nike (negative growth). DCF with $2.1B FCF, 10% discount rate, 0% terminal growth = ~$21B enterprise value (~$27/share equity value after debt). BofA target $30. Blending DCF ($27), negative growth Graham ($14.28), and a 20% brand quality premium yields an entry zone of $24-$28.50 (midpoint $26.25). The current price of $34.71 is $6.21 ABOVE the top of our entry zone — do NOT initiate any new long positions here.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is NKE a halal stock?
Yes, NIKE, Inc. (NKE) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for NKE?
NIKE, Inc. (NKE) has a Plutrex AI rating of 22.0/100 with a Strong Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is NKE a good investment?
According to Plutrex AI, NKE has a Strong Sell rating (22.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in NKE?
US stocks like NKE can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in NKE?
Plutrex AI identifies the main risks for NKE by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.